Study Title: A PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN ALONE OR COMBINED WITH EITHER TRASTUZUMAB AND HYALURONIDASE-OYSK (HERCEPTIN HYLECTA) OR PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF (PHESGO) IN HER2 POSITIVE, STAGE I-IV ENDOMETRIAL SEROUS CARCINOMA OR CARCINOSARCOMA
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Orr, Brian, at orrb@musc.edu.Study Coordinator, Knox, Crystal, at knoxc@musc.edu.Trial opened at the following institutions: Medical University of South Carolina